Surjit Bhimarao Dixit
Keine laufenden Positionen mehr
Profil
Surjit Bhimarao Dixit worked as Vice President-Technology at Zymeworks BC, Inc. Prior to that, he worked as Coordinator-Computational Molecular Biophysics at Wesleyan University from 2005 to 2007 and as Research Associate at Henri Poincaré University from 1999 to 2001.
Dixit holds a doctorate degree from Indian Institute of Technology New Delhi.
Ehemalige bekannte Positionen von Surjit Bhimarao Dixit
| Unternehmen | Position | Ende |
|---|---|---|
| Wesleyan University | Corporate Officer/Principal | 01.07.2007 |
| Henri Poincaré University | Corporate Officer/Principal | 01.02.2001 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Surjit Bhimarao Dixit
| Indian Institute of Technology New Delhi | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
